{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T10:15:52Z","timestamp":1697451352927},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,12,20]],"date-time":"2002-12-20T00:00:00Z","timestamp":1040342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> We previously showed that serum beta\u20102\u2010microglobulin (\u03b22m)\u2010free human leucocyte antigen (HLA) class I heavy chain (FHC) levels were increased in MM and correlate with disease activity. The present investigation, carried out in 124 multiple myeloma patients, studied the expression of the three size variants of FHC, namely the 42\u2003kDa intact heavy chain (A variant, AV), released through a shedding process, and the truncated FHC (tFHC) 39\u2003kDa (BV) and 36\u201335\u2003kDa (CV) released by means of membrane\u2010type metalloprotease activity. The increase in FHC correlated with a high expression percentage of BV (<jats:italic>r\u2003=<\/jats:italic>\u20030\u00b732, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b70002) and tFHC (<jats:italic>r\u2003=<\/jats:italic>\u20030\u00b742, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001), which could help to discriminate multiple myeloma from monoclonal gammopathy of undetermined significance (tFHC mean ratio\u2003=\u20033\u00b72; Mann\u2013Whitney <jats:italic>U<\/jats:italic>\u2010test, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001). tFHC levels highly correlated with other disease activity markers, namely haemoglobin (<jats:italic>r\u2003=<\/jats:italic>\u2003\u22120\u00b735; Spearman's rank, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b70001), percentage of bone marrow plasma cells (<jats:italic>r\u2003=<\/jats:italic>\u20030\u00b74, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001) and \u03b22m levels (<jats:italic>r\u2003=<\/jats:italic>\u20030\u00b736, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001), while only the last barely correlated (<jats:italic>r\u2003=<\/jats:italic>\u20030\u00b72, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b703) with AV. Finally, the 0\u00b74, 0\u00b757 and 0\u00b771\u2003mg\/l BV, tFHC and (to a lesser extent) FHC cut\u2010off values divided patients into two groups with different survival curves (<jats:italic>P\u2003=<\/jats:italic>\u20030\u00b70005, <jats:italic>P\u2003=<\/jats:italic>\u20030\u00b70025 and <jats:italic>P\u2003=<\/jats:italic>\u20030\u00b704 respectively). These data are in favour of a correlation between disease aggressiveness and cleavage of these variants by membrane\u2010type metalloprotease enzymes.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2003.03945.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:50:00Z","timestamp":1047365400000},"page":"36-43","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Size variants of beta\u20102\u2010microglobulin\u2010free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma"],"prefix":"10.1111","volume":"120","author":[{"given":"Federico","family":"Perosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Prete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Luccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,12,20]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.4049\/jimmunol.163.10.5723","article-title":"Production of metalloproteinase\u20107 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase\u20102 activation","volume":"163","author":"Barille S.","year":"1999","journal-title":"Journal of Immunology"},{"key":"e_1_2_16_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1998.tb03022.x"},{"key":"e_1_2_16_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(99)00013-0"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(98)00032-9"},{"key":"e_1_2_16_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(00)00210-X"},{"key":"e_1_2_16_7_1","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1016\/S0021-9258(17)37430-6","article-title":"Soluble beta 2\u2010microglobulin\u2010free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease","volume":"269","author":"Demaria S.","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_16_8_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.6.3275"},{"key":"e_1_2_16_9_1","first-page":"243","volume-title":"Recent Advances in Haematology","author":"Durie B.G.","year":"1977"},{"key":"e_1_2_16_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.4.823.823"},{"key":"e_1_2_16_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.12.3382.3382"},{"key":"e_1_2_16_12_1","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/S0021-9258(19)67850-6","article-title":"Biochemical characterization of 39\u2010kDa class I histocompatibility antigen in plasma. A secretable membrane protein derived from transmembrane domain deletion","volume":"266","author":"Haga J.A.","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_16_13_1","first-page":"185","volume-title":"Melanogenesis and Malignant Melanoma: Biochemistry, Cell Biology, Molecular Biology, Pathophysiology, Diagnosis and Treatment","author":"Hamby C.V.","year":"1996"},{"key":"e_1_2_16_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(94)90074-4"},{"key":"e_1_2_16_15_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.163.5.1173"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(94)90075-2"},{"key":"e_1_2_16_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/227680a0"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005173222005"},{"key":"e_1_2_16_19_1","first-page":"254","article-title":"Multiple myeloma: prognostic factors and treatment modalities","volume":"40","author":"Michiels J.J.","year":"1992","journal-title":"Netherlands Journal of Medicine"},{"key":"e_1_2_16_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(90)90458-8"},{"key":"e_1_2_16_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01635.x"},{"key":"e_1_2_16_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(99)00081-6"},{"key":"e_1_2_16_23_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.2000.550407.x"},{"key":"e_1_2_16_24_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026468001834"},{"key":"e_1_2_16_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(99)00011-7"},{"key":"e_1_2_16_26_1","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.4049\/jimmunol.137.7.2299","article-title":"Monoclonal antibodies raised against denatured HLA\u2010B locus heavy chains permit biochemical characterization of certain HLA\u2010C locus products","volume":"137","author":"Stam N.J.","year":"1986","journal-title":"Journal of Immunology"},{"key":"e_1_2_16_27_1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4049\/jimmunol.136.3.1007","article-title":"Mapping the idiotopes of a monoclonal anti\u2010myoglobin antibody with syngeneic monoclonal anti\u2010idiotypic antibodies: detection of a common idiotope","volume":"136","author":"Streicher H.Z.","year":"1986","journal-title":"Journal of Immunology"},{"key":"e_1_2_16_28_1","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4049\/jimmunol.148.10.3202","article-title":"Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain","volume":"148","author":"Tanabe M.","year":"1992","journal-title":"Journal of Immunology"},{"key":"e_1_2_16_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.5.1780.1780"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.03945.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.03945.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2003.03945.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:38:27Z","timestamp":1697413107000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2003.03945.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1046\/j.1365-2141.2003.03945.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2003.03945.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,20]]},"assertion":[{"value":"2002-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}